Literature DB >> 10712399

Cholesterol-lowering treatment is associated with improvement in coronary vascular remodeling and endothelial function in patients with normal or mildly diseased coronary arteries.

S Hamasaki1, S T Higano, J A Suwaidi, R A Nishimura, K Miyauchi, D R Holmes, A Lerman.   

Abstract

Coronary vascular remodeling and altered endothelial function have been described in the early stages of native atherosclerosis. The purpose of this study was to evaluate the association between cholesterol-lowering therapy and coronary vascular remodeling and endothelial function in patients with normal or mildly diseases coronary arteries. Patients (N=101) with normal or mildly diseased coronary arteries by coronary angiography underwent intravascular ultrasound examination of the left anterior descending coronary artery. Vessel and lumen area, atherosclerotic plaque area, and plaque morphology were evaluated. Vascular reactivity was examined with the use of intracoronary adenosine, acetylcholine, and nitroglycerin. Patients were divided into 3 groups based on the total cholesterol levels: group 1 (n=25), patients with a history of hypercholesterolemia adequately treated (total cholesterol <240 mg/dL); group 2 (n=26), patients with hypercholesterolemia not adequately controlled (total cholesterol >/=240 mg/dL); and group 3 (n=50), patients without hypercholesterolemia. Vessel area and lumen area were significantly greater in groups 1 and 3 than in group 2 (for respective values in groups 1, 2, and 3: vessel area 11.9+/-0.5, 10.6+/-0.4, and 11.8+/-0.4 mm(2), both P<0.05; lumen area 8.3+/-0.4, 6.9+/-0.3, and 8.9+/-0.3 mm(2), both P<0.01). However, plaque areas in groups 1 and 2 were similar. Furthermore, acetylcholine-induced percent increases in coronary blood flow were significantly greater in groups 1 and 3 than in group 2 (for respective values in groups 1, 2, and 3: 70.5+/-20.1%, 22.8+/-13.7%, and 68.6+/-14.8%, both P<0. 05). Cholesterol-lowering treatment is associated with an improvement in coronary lumen area that results not from a decrease in plaque area but from an increase in vessel area, reflecting vascular remodeling. Additionally, this adaptive process may occur in association with an improvement of endothelium-dependent vasodilation of the resistance coronary artery.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10712399     DOI: 10.1161/01.atv.20.3.737

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  7 in total

Review 1.  Emergence of Nonobstructive Coronary Artery Disease: A Woman's Problem and Need for Change in Definition on Angiography.

Authors:  Carl J Pepine; Keith C Ferdinand; Leslee J Shaw; Kelly Ann Light-McGroary; Rashmee U Shah; Martha Gulati; Claire Duvernoy; Mary Norine Walsh; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2015-10-27       Impact factor: 24.094

2.  Shear-stress-mediated arterial remodeling in atherosclerosis: too much of a good thing?

Authors:  Annemarie E Silver; Joseph A Vita
Journal:  Circulation       Date:  2006-06-20       Impact factor: 29.690

Review 3.  The endothelium: dysfunction and beyond.

Authors:  J Herrmann; A Lerman
Journal:  J Nucl Cardiol       Date:  2001 Mar-Apr       Impact factor: 5.952

4.  Association of plaque composition and vessel remodeling in atherosclerotic renal artery stenosis: a comparison with coronary artery disease.

Authors:  Tetsuro Kataoka; Verghese Mathew; Ronen Rubinshtein; Charanjit S Rihal; Ryan Lennon; Lilach O Lerman; Amir Lerman
Journal:  JACC Cardiovasc Imaging       Date:  2009-03

Review 5.  Micronised fenofibrate: an updated review of its clinical efficacy in the management of dyslipidaemia.

Authors:  Gillian M Keating; Douglas Ormrod
Journal:  Drugs       Date:  2002       Impact factor: 9.546

6.  Reduced LDL-cholesterol levels in patients with coronary artery disease are paralleled by improved endothelial function: An observational study in patients from 2003 and 2007.

Authors:  Christian Delles; Jane A Dymott; Ulf Neisius; J Paul Rocchiccioli; Gavin J Bryce; María U Moreno; David M Carty; Geoffrey A Berg; Carlene A Hamilton; Anna F Dominiczak
Journal:  Atherosclerosis       Date:  2010-01-21       Impact factor: 5.162

Review 7.  Treatment of coronary microvascular dysfunction.

Authors:  C Noel Bairey Merz; Carl J Pepine; Hiroki Shimokawa; Colin Berry
Journal:  Cardiovasc Res       Date:  2020-03-01       Impact factor: 13.081

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.